Varicella also known as chicken pox, is highly contagious, and affects mainly children of age 2‒8 years. It is caused by the varicella zoster virus (VZV), the virus which also causes shingles (herpes zoster). Symptoms of varicella includes characteristic skin rash that forms small, itchy blisters, which eventually scab over. Other symptoms may include fever, tiredness, and headaches. It mainly starts on the chest, back, face and then spreads to the rest of the body. Immunization is the most effective way for prevention of varicella.
The global varicella vaccine market is mainly driven by rising awareness for immunization, growing number of new born babies globally and various initiatives for making vaccine available to low- and middle-income countries. Increasing government support for vaccine development is also playing a pivotal role in contributing to growth of the market globally. However, high cost of vaccine development and religious beliefs among certain communities against vaccination are likely to restrain the market growth to a certain extent.
The global varicella vaccine market has been analyzed from three perspectives: Patient Type, Product Type and Region.
Based on patient type, the market has been segmented into pediatric patients and adult patients. The pediatric patients segment accounted for the largest share in the market owing to high vulnerability of varicella infection in children. Inclusion of varicella vaccine in childhood immunization programme by various government agencies around the world can also be attributed to the growth of the market.
Based on product type, the varicella vaccine market has been segmented into monovalent varicella vaccine and combination varicella vaccine. Monovalent varicella vaccine segment holds the largest share in the market. The growth of the segment can mainly be attributed to availability of large number of monovalent varicella vaccines in market as compared to combination varicella vaccines. At present, there are only two combination varicella vaccines licensed in the market, namely, ProQuad and Priorix-Tetra. Whereas, there are more than eight monovalent varicella vaccine licensed in the market, namely, VARIVAX, Varilrix, VARICELLA VACCINE LIVE ATTENUATED "BIKEN”, Varicella Vaccine-GCC inj., ZUVICELLA, SKY Varicella, among others.
Based on region, the global varicella vaccine market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW). North America dominated the varicella vaccine market, followed by Asia Pacific. The large share of North America in the global market can largely be attributed to the presence of key prominent players, outbreak of chicken pox, and increasing government initiatives for vaccination.
The varicella vaccine market is marked by presence of prominent players such as GlaxoSmithKline plc., Merck & Co., Inc., Sinovac Biotech Ltd., BIKEN, Changchun BCHT Biotechnology Co., Ltd, Green Cross Corp., Zuventus HealthCare Ltd., BIO-MED, SK bioscience., among others.
• In Dec 2019, Sinovac Biotech Ltd. announced that the China National Medical Products Administration (NMPA) has approved and issued a product license for the company’s varicella vaccine to prevent the varicella-zoster virus in children from 1 to 12 years of age
• In Dec 2019, SK bioscience’s Sky varicella received pre-qualification (PQ) certification from the World Health Organization (WHO). This certification makes company eligible to participate in international bids organized by U.N. agencies, such as UNICEF and Pan American Health Organization (PAHO)
• Quantitative (market size and forecasts) and qualitative insights of the market across years - historical years, current year and forecasted years
• Deep-rooted insights on headwinds, tailwinds and opportunities prevailing in the market
• Quantitative (market size and forecasts) and qualitative insights at segment and sub-segment level
• Comprehensive quantitative (market size and forecasts) and qualitative insights on geographic, regional and country level markets
• Granular insights on the competitive landscape prevailing in the market
|Market Size Period||2018-2031|
|Market Segments||Asessment of Varicella Vaccines Market By:
• Patient Type
|Geographic Scope||• North America
◦ Rest of Europe (RoE)
• Asia Pacific
◦ Rest of Asia Pacific (RoAPAC)
• Rest of the World
◦ Latin America
◦ Middle East & Africa
|Companies Covered||GlaxoSmithKline plc., Merck & Co., Inc., Sinovac Biotech Ltd., BIKEN, Changchun BCHT Biotechnology Co., Ltd, Green Cross Corp., Zuventus HealthCare Ltd., BIO-MED, SK bioscience., among others.|
1 RESEARCH ENVELOPE
1.1 Market Classification
1.2 Scope of the Study
1.2.1 Timeline Considered for Market Study
· Historic Years – 2018 & 2019
· Base Year – 2020
· Projected Years – 2021 to 2031
1.3 Currency Used in the Report
2 RESEARCH METHODOLOGY
2.1 Research Approach
2.2 Data Collection Methodology
2.3 Data Sources
2.3.1 Secondary Sources
2.3.2 Primary Sources
2.4 Market Crackdown Methodology
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Data Forecasting Model
2.6 Limitations and Assumptions for Study
3 HEADWINDS & TAILWINDS ASSESSMENT
4 MARKET OPPORTUNITIES ASSESSMENT
5 PREMIUM INSIGHTS
5.1 Key Market Trends
5.2 Key Players & Their Competitive Positioning (2020)
5.3 COVID-19 Impact Assessment
5.4 Pipeline Assessment
6 GLOBAL VARICELLA VACCINE MARKET - ANALYSIS & FORECAST, BY PATIENT TYPE
6.1 Pediatric Patients
6.2 Adult Patients
7 GLOBAL VARICELLA VACCINE MARKET - ANALYSIS & FORECAST, BY PRODUCT TYPE
7.1 Monovalent Varicella Vaccine
7.2 Combination Varicella Vaccine
8 GLOBAL VARICELLA VACCINE MARKET - ANALYSIS & FORECAST, BY REGION
8.1 North America Varicella Vaccine Market
8.1.1 North America Varicella Vaccine Market, By Country
8.1.2 North America Varicella Vaccine Market, By Patient Type
8.1.3 North America Varicella Vaccine Market, By Product Type
8.2 Europe Varicella Vaccine Market
8.2.1 Europe Varicella Vaccine Market, By Country/Region
18.104.22.168 Rest of Europe (ROE)
8.2.2 Europe Varicella Vaccine Market, By Patient Type
8.2.3 Europe Varicella Vaccine Market, By Product Type
8.3 Asia Pacific Varicella Vaccine Market
8.3.1 Asia Pacific Varicella Vaccine Market, By Country/Region
22.214.171.124 Rest of Asia Pacific (RoAPAC)
8.3.2 Asia Pacific Varicella Vaccine Market, By Patient Type
8.3.3 Asia Pacific Varicella Vaccine Market, By Product Type
8.4 Rest of the World (RoW) Varicella Vaccine Market
8.4.1 Rest of the World Varicella Vaccine Market, By Region
126.96.36.199 Latin America
188.8.131.52 Middle East & Africa
8.4.2 Rest of The World Varicella Vaccine Market, By Patient Type
8.4.3 Rest of The World Varicella Vaccine Market, By Product Type
9 COMPANY PROFILES
9.1 GlaxoSmithKline plc.
9.1.1 Business Overview
9.1.2 Financial Metrics*
9.1.3 Product Portfolio
9.1.4 Key Developments
9.2 Merck & Co., Inc.
9.3 Sinovac Biotech Ltd.
9.5 Changchun BCHT Biotechnology Co., Ltd
9.6 Green Cross Corp.
9.7 Zuventus HealthCare Ltd.
9.9 SK bioscience.
9.10 Other Prominent Players
*Insights on financial metrics is subject to availability of information in the public domain
3D printing also known as additive manufacturing is a process of making three dimensional solid objects from a CAD model or a digital 3D model. The term "3D printing" can refer to a variety of proc...
Hemophilia is a rare inherited bleeding disorder in which the blood does not clot properly which leads to spontaneous bleeding as well as bleeding following injuries or surgery. Blood contains prot...
The term halal is particularly associated with Islamic dietary laws and especially meat processed & prepared in accordance with those requirements. Halal is an Arabic word that means permissible. H...
Urinalysis is a test & analysis of urine to detect and manage a wide range of disorders, namely urinary tract infections, kidney disease and diabetes, among others. It includes a group of physical,...
Allergy is an exaggerated reaction by the immune system in response to exposure to certain foreign substances. These foreign substances are called as allergens and includes pollens, dust mites, mol...
Micro-catheters are a broad term, often used to describe thin wall, small diameter catheters and delivery devices used in minimally invasive applications. Its small build makes it ideal for navigat...
Remote patient monitoring (RPM) is a subset of telehealth. It is a technology that enables monitoring of patients outside of conventional clinical settings.
Femtech is a term applied to a category of software, diagnostics, products and services that focus on women's health.
Telehealth is a broader array of digital healthcare activities & services and can be defined as distribution of health-related services & information including medical care, provider & patient educ...
Sleep apnea is a condition where breathing is interrupted during sleep. It is considered a serious sleep disorder in which breathing repeatedly stops and starts.
A MedTech CDMO is a company that serves other companies in the medical device industry on contract basis and provides comprehensive services ranging from design & development, prototyping, tooling,...
Wearable medical devices are electronic devices that are designed to collect the data of users' personal health and exercise. It offers a convenient means of monitoring many physiological features,...
A contract research organization (CRO) also known as a clinical research organization, is an organization that provides services to pharmaceutical, biotechnology, and medical device companies.
Cell and gene therapy (CGT) companies partner with CGT CDMOs to get support on discovery, preclinical, clinical stages, CGT product development, manufacturing, and commercial manufacturing.
Contract Research, Development and Manufacturing (CRDMO) provides a fully integrated suite of end-to-end solutions for discovery, development, and manufacturing to meet all future market demands.